Corvus Pharmaceuticals, Inc. (CRVS) has a market capitalization of $1.28B and trades at $15.25. The 52-week range is 2.54-26.95.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -80.3, Earnings Per Share (EPS) of $-0.19.
The stock has a beta of 0.97, operates in the Healthcare sector.
